Evidence map›Paper›PMID 42781020›Full record

ArticleFrontiers in microbiology2026

Fructooligosaccharides-driven metabolism of a defined

Margherita Finazzi, Federica Bovio, Matilde Forcella, Marina Lasagni, Paola Fusi, Jessica Zampolli, Patrizia Di Gennaro

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Margherita FinazziDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Federica BovioDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Matilde ForcellaDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Marina LasagniDepartment of Earth and Environmental Sciences, University of Milano-Bicocca, Milano, Italy.
Paola FusiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Jessica ZampolliDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.
Patrizia Di GennaroDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Metabolic dysfunction-associated steatotic liver disease may be influenced by human gut microbiota-derived metabolites. Fructooligosaccharides (FOS) and probiotic Methods: A previously validated minimal core community, representing metabolic functions of the human gut microbiota, was supplemented with the probiotic consortium and cultured in the presence of FOS with an average degree of polymerization ~10. Results and discussion: FOS supported growth of both probiotic and minimal core members in a strain-dependent manner within the community, with higher growth levels of

Indexed as

fructooligosaccharidesgut-liver axisin vitro reconstructed human gut microbiota modelLactobacilluslipid accumulationprobioticsshort-chain fatty acidssteatosis

Identifiers

PMID42781020
PMCPMC13599725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.